<DOC>
	<DOC>NCT01187589</DOC>
	<brief_summary>This study is aimed at finding the effect of PulseHalerâ„¢ with Albuterol on Lung Deposition of Aerosol and on Pulmonary Functions in COPD Patients</brief_summary>
	<brief_title>PulseHaler Drug Deposition Study in Chronic Obstructive Pulmonary Disease Patients</brief_title>
	<detailed_description />
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Diagnosis of Chronic Obstructive Pulmonary Disease (COPD), established for at least 1 year Postbronchodilator FEV1/FVC &lt; 0.7 Postbronchodilator FEV1 in the range 30% 70% predicted Age: 40 years or older Patient signed the informed consent form Pneumothorax in the past, per anamnesis. Women at the age of fertility, who are pregnant, or plan pregnancy, or do not use contraceptive. Severe cardiac disease, e.g., Congestive Heart Failure (CHF) grade 3 or higher Coronary Artery Bypass Graft (CABG) or Acute Myocardial Infarction (MI) within last 3 months Other severe systemic disease Noncooperative or noncompliant patient</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>